Elevance Health Inc. (ELV) Misses Q3 EPS by $1.29, Beats on Revenue

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $8.37, $1.29 worse than the analyst estimate of $9.66. Revenue for the quarter came in at $44.7 billion versus the consensus estimate of $43.46 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Goldman Sachs Reiterates Buy Rating on NetEase.com (NTES)
• GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing